"Apoptosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
| Descriptor ID |
D017209
|
| MeSH Number(s) |
G04.146.160
|
| Concept/Terms |
Apoptosis- Apoptosis
- Programmed Cell Death, Type I
|
Below are MeSH descriptors whose meaning is more general than "Apoptosis".
Below are MeSH descriptors whose meaning is more specific than "Apoptosis".
This graph shows the total number of publications written about "Apoptosis" by people in this website by year, and whether "Apoptosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 13 | 4 | 17 |
| 1997 | 23 | 8 | 31 |
| 1998 | 25 | 14 | 39 |
| 1999 | 22 | 9 | 31 |
| 2000 | 25 | 23 | 48 |
| 2001 | 36 | 20 | 56 |
| 2002 | 38 | 27 | 65 |
| 2003 | 43 | 31 | 74 |
| 2004 | 36 | 47 | 83 |
| 2005 | 26 | 24 | 50 |
| 2006 | 23 | 40 | 63 |
| 2007 | 22 | 35 | 57 |
| 2008 | 21 | 34 | 55 |
| 2009 | 12 | 38 | 50 |
| 2010 | 14 | 46 | 60 |
| 2011 | 13 | 33 | 46 |
| 2012 | 19 | 40 | 59 |
| 2013 | 14 | 47 | 61 |
| 2014 | 13 | 44 | 57 |
| 2015 | 14 | 34 | 48 |
| 2016 | 9 | 42 | 51 |
| 2017 | 5 | 26 | 31 |
| 2018 | 13 | 35 | 48 |
| 2019 | 7 | 15 | 22 |
| 2020 | 4 | 20 | 24 |
| 2021 | 1 | 28 | 29 |
| 2022 | 2 | 6 | 8 |
| 2023 | 0 | 8 | 8 |
| 2024 | 4 | 8 | 12 |
| 2025 | 6 | 8 | 14 |
| 2026 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Apoptosis" by people in Profiles.
-
Thymol-based derivatives as anticancer agents: design, synthesis, biological evaluation, and molecular docking studies. Bioorg Chem. 2026 Nov 05; 183:110587.
-
Stabilized phospholipid-topotecan prodrug particles increase vascular permeability and ultrasound-enhanced neuroblastoma delivery. Int J Pharm. 2026 Oct 05; 703:127283.
-
Critical role of endothelial regulator of G protein signaling 5 in postnatal angiogenesis. Angiogenesis. 2026 Aug 01; 29(4).
-
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia. Clin Cancer Res. 2026 Jul 17; 32(14):3018-3030.
-
SMSC-EVs restore chondrocyte function through S1PR1-mTORC2-mediated mitochondrial fusion and GPS2-HDAC1-driven epigenetic regulation. Osteoarthritis Cartilage. 2026 Nov; 34(11):1617-1632.
-
Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers. Proc Natl Acad Sci U S A. 2026 May 12; 123(19):e2528911123.
-
Dynamin 2 Regulates Mitochondrial Mitotic Fission in Pulmonary Hypertension. Circ Res. 2026 May 22; 138(11):e327028.
-
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes. Signal Transduct Target Ther. 2026 Apr 27; 11(1).
-
Phthalate Metabolite, Mono(2-Ethyl-5-Hydroxyhexyl) Phthalate (MEHHP), Promotes Uterine-Fibroid-Associated Phenotypes in Myometrial Stem Cell-Derived 3D Organoids. Environ Toxicol. 2026 Oct; 41(10):975-997.
-
RLIP depletion suppresses ovarian cancer growth and metastasis. J Ovarian Res. 2026 Jan 30; 19(1).